Exodus Point Capital Management, LP Inovio Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.39 - $0.94 $29,558 - $71,244	75,792 New	75,792 $34,000
Q3 2022 Nov 10, 2022	BUY	$1.66 - $2.79 $88,883 - $149,387	53,544 New	53,544 $92,000
Q2 2022 Aug 19, 2022	SELL	$1.44 - $3.98 $89,637 - $247,747	-62,248 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $98,604 - $172,640	-33,200 Reduced 34.78%	62,248 $223,000
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $476,285 - $712,042	95,448 New	95,448 $476,000
Q3 2021 Nov 15, 2021	SELL	$7.16 - $9.69 $490,689 - $664,075	-68,532 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $231,332 - $372,433	37,132 Added 118.25%	68,532 $635,000
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $10,113 - $19,470	1,148 Added 3.79%	31,400 $291,000
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $257,142 - $388,738	30,252 New	30,252 $268,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.